{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:34:26Z","timestamp":1794548066230,"version":"4.9.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00018","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:44:47Z","timestamp":1548233087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats"],"prefix":"10.3389","volume":"10","author":[{"given":"\u0160\u00e1rka","family":"Vackov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Kopkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u0148a","family":"Kikerlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Huskov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Kompanowska-Jezierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Imig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"T\u00e1borsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Melenovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/729497","article-title":"Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.","volume":"2011","author":"Abassi","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.vph.2015.08.013","article-title":"Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.","volume":"73","author":"Al\u00e1nov\u00e1","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-018-0406-8","article-title":"Cardiorenal interactions revisited: how to improve heart failure outcomes in patients with chronic kidney disease.","author":"Arrigo","year":"2018","journal-title":"Curr. Heart Fail."},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1042\/CS20100527","article-title":"Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats.","volume":"121","author":"Benes","year":"2011","journal-title":"Clin. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association.","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrneph.2013.250","article-title":"Cardiorenal syndrome \u2013 current understanding and future perspectives.","volume":"10","author":"Braam","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure.","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"H2071","DOI":"10.1152\/ajpheart.1996.271.5.H2071","article-title":"Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload.","volume":"40","author":"Brower","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.hlc.2015.02.023","article-title":"Differential effects of prevention and reversal treatment with lisinopril on left ventricular remodelling in a rat model of heart failure.","volume":"24","author":"Brower","year":"2015","journal-title":"Heart Lung Circ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.prostaglandins.2015.05.004","article-title":"Arachidonic acid monooxygenase: genetic and biochemical approaches to physiological\/pathophysiological relevance.","volume":"120","author":"Capdevila","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000487902","article-title":"Combined inhibition of soluble epoxide hydrolase and renin-angiotensin system exhibits superior renoprotection to renin-angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats with established chronic kidney disease.","volume":"43","author":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/1440-1681.12419","article-title":"Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.","volume":"42","author":"\u010cervenka","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/1440-1681.12619","article-title":"Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.","volume":"43","author":"\u010cervenka","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.acthis.2014.08.006","article-title":"Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.","volume":"116","author":"Cohen-Segev","year":"2014","journal-title":"Acta Histochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/10641963.2016.1182182","article-title":"Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.","volume":"38","author":"Dole\u017eelov\u00e1","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MAJ.0b013e318232750d","article-title":"Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part I.","volume":"342","author":"Dube","year":"2011","journal-title":"Am. J. Med. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R321","DOI":"10.1152\/ajpregu.00606.2011","article-title":"Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.","volume":"302","author":"Elmarakby","year":"2012","journal-title":"Am. J. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of cytochrome P450 metabolites of arachidonic acid in nephrology.","volume":"28","author":"Fan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1124\/pr.113.007781","article-title":"The pharmacology of the cytochrome P450 epoxygenase\/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.","volume":"66","author":"Fleming","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"F902","DOI":"10.1152\/ajprenal.1992.262.5.F902","article-title":"Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.","volume":"262","author":"Fox","year":"1992","journal-title":"Am J Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction.","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF02001401","article-title":"Aorto-caval fistula in the rat. An experimental model of heart volume overloading.","volume":"75","author":"Hatt","year":"1980","journal-title":"Basic Res. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1113\/jphysiol.2010.199505","article-title":"Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.","volume":"589","author":"Honetschlagerova","year":"2011","journal-title":"J. Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2017.12.006","article-title":"Management of heart failure in advancing CKD: core curriculum 2018.","volume":"72","author":"House","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/RES.0b013e3182582523","article-title":"Animal models of heart failure: a scientific statement from the American Heart Association.","volume":"111","author":"Houser","year":"2012","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/1440-1681.12553","article-title":"Intrarenal alterations of the angiotensin-converting type 2\/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.","volume":"43","author":"Huskov\u00e1","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000092981","article-title":"Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.","volume":"29","author":"Huskov\u00e1","year":"","journal-title":"Kidney Blood Press Res."},{"key":"B28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.hjh.0000209988.51606.c7","article-title":"Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.","volume":"24","author":"Huskov\u00e1","year":"","journal-title":"J Hypertens."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.06.015","article-title":"Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapies.","author":"Imig","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function.","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives.","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.amjms.2016.09.008","article-title":"Fenefibrate attenuates malignant hypertension by suppression of the renin-angiotensin system: a study in Cyp1a1-Ren-2 transgenic rats.","volume":"352","author":"J\u00edchov\u00e1","year":"2016","journal-title":"Am. J. Med. Sci."},{"key":"B33","first-page":"401","article-title":"Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.","volume":"67","author":"Kala","year":"2018","journal-title":"Physiol. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.HYP.0000050102.90932.CF","article-title":"Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension.","volume":"41","author":"Kobori","year":"2003","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00424-012-1143-6","article-title":"Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.","volume":"465","author":"Kobori","year":"2013","journal-title":"Pflugers Arch."},{"key":"B36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1159\/000339883","article-title":"Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.","volume":"35","author":"Kopkan","year":"2012","journal-title":"Kidney Blood Press Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1440-1681.12204","article-title":"Inhibition of soluble epoxide hydrolase is renoprotective in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats.","volume":"41","author":"Kujal","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ilar.32.3.23","article-title":"SHF\/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure.","volume":"32","author":"McCune","year":"1990","journal-title":"Ilar News"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1159\/000493657","article-title":"Kidney response to heart failure: proteomic analysis of cardiorenal syndrome.","volume":"43","author":"Melenovsky","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000331562","article-title":"The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula.","volume":"35","author":"Melenovsky","year":"2012","journal-title":"Kidney Blood Press Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehx035","article-title":"Renal sodium avidity in heart failure: from pathophysiology to treatment strategies.","volume":"38","author":"Mullens","year":"2017","journal-title":"Eur. Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11010-009-0361-5","article-title":"Early predictors of cardiac decompensation in experimental volume overload.","volume":"2010","author":"Oliver-Dussault","year":"2010","journal-title":"Mol. Cell Biochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(16)30969-2","article-title":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.","volume":"389","author":"Packer","year":"2017","journal-title":"Lancet"},{"key":"B45","first-page":"S2","article-title":"Spontaneous glomerulosclerosis: insights from the fawn-hooded rat.","volume":"45","author":"Proovoost","year":"1994","journal-title":"Kidney Int. Suppl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1373\/clinchem.2003.025775","article-title":"Measurement of 20-hydroxyeicosatetraenoic acid in human urine by gas chromatography-mass spectrometry.","volume":"50","author":"Rivera","year":"2004","journal-title":"Clin. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function.","volume":"192","author":"Rocic","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function.","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management.","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/10641963.2016.1235184","article-title":"Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5\/6 nephrectomized Ren-2 transgenic rats.","volume":"39","author":"Sedl\u00e1kov\u00e1","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/1440-1681.12310","article-title":"Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.","volume":"41","author":"Sporkov\u00e1","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B52","year":"2015","journal-title":"USRDS. Annual Data Report"},{"key":"B53","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure.","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:44:50Z","timestamp":1548233090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":53,"alternative-id":["10.3389\/fphar.2019.00018"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00018","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"article-number":"18"}}